Carlo Bruch
Interim Chief Financial Officer
Replay available
Cibus, Inc. (NASDAQ: CBUS) Q2 2025 earnings conference call, held 2025-08-14. Replay captured from the company's public earnings webcast.

Interim Chief Financial Officer
Co-founder, Interim Chief Executive Officer, President and COO
Co-founder and Chief Scientific Officer
Analyst, AGP
Analyst, Canaccord Genuity
Analyst, H.C. Wainwright
Analyst, Sidoti & Company
Please also note today's event is being recorded. At this time, I would like to turn the conference over to Carlo Bruch, Interim Chief Financial Officer. Please go ahead. Thank you and good afternoon. I would like to thank you for taking time to join us for the second quarter 2025 Financial Results and Business Update conference call and webcast. Presenting with me today is Peter Beethem, co-founder, interim chief executive officer, president and COO, and Greg Gochel, co-founder and our chief scientific officer. Before we begin the call, I'd like to remind everyone that statements made on the call and webcast, including those regarding future financial results, and future operational goals and industry prospects are forward-looking and may be subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the call. Please refer to CBIS SEC findings for a list of associated risks. This conference call is being webcast. The webcast link, along with our press release and corporate presentation, are available on the investor relations section of cbis.com to assist you in your analysis of our business. And with that, I would now like to turn the call over to Peter. Thanks, Carlo, and good afternoon to everyone. I'd like to start today's call to recognize that our team here at CBUS remains laser-focused on delivering our targeted near-term revenues. Our second quarter demonstrates continued execution toward our commercial objectives. with clear progress across our focus programs in rice and partner funded and or supported sustainable ingredients, including bio fragrances that are positioning SEBAS to begin recognizing initial revenue in 2026. Every quarter we are getting closer to that pivotal initial revenue mome...